Tuomo Karjalainen Marialuisa Tamborra

1
Implementation of Environment and Health Action
Plan RESEARCH ASPECTS

• Tuomo Karjalainen Marialuisa Tamborra
• European Commission Research Directorate-General
• Directorate I (Environment)
• Tuomo.Karjalainen_at_cec.eu.int Marialuisa.Tamborra_at_
  cec.eu.int

Consultative Group on Environment and Health, 19
April 2006, Brussels
2
Research themes in the Environment Health
Action Plan

• Integrating and exploiting research results for
  policy development (Action 5)
• Analysis of environment/health interactions to
  improve understanding prevention of the
  priority diseases (putting emphasis on children,
  e.g. asthma, allergy, neuro-immune disorders,
  cancers, endocrine disruption) (Action 6)
• Developing methodologies to assess better the
  risks coming from environmental factors and
  improving economic valuation (externalities
  concept) and impact analyses of prevention
  strategies (Action 7)
• Launching research on emerging issues (Action 8)
• climate change health (e.g. spreading of
  emerging diseases)
• water pollution (e.g. emerging pathogens in
  drinking water)

3
Implementation of the EH Action Plan structure
of the presentation

• Implementing Action 5
• Building on FP5 projects
• Relevant FP6 projects
• Implementing Action 6
• Building on FP5 projects
• Relevant FP6 projects
• Projects contributing to human biomonitoring
• Implementing Action 7
• Relevant FP6 projects
• Implementing Action 8
• Relevant FP6 projects
• Dissemination activities

4
Implementing Action 5 Integrating and exploiting
research results for policy development
5
Implementing Action 5 FP5 projects
6
Implementing Action 5 FP5 projects 2 examples
7
Implementing Action 5 FP6 projects (2002-2006)
8
Implementing Action 5
FP6 projects (2002-2006)
9
Implementing Action 5 FP6 projects (2002-2006)
10
Implementing Action 5 Supporting the mid-term
review

• Objective
• The aim is to review, as part of the mid-term
  review of the Environment and Health Action Plan,
  the progress made in the priority research areas
  for the identification and dissemination of
  results with high policy relevance.
• The assessment should exploit emerging
  environmental threats not yet identified as
  priorities in the Action Plan.

SSA launched under last call of Global Change
Ecosystems
NO PROJECT FUNDED due to budget constraints
Setting up a Group of Experts with review tasks
11
Action 6 Analysis of environment/health
interactions to improve understanding
prevention of the priority diseases (putting
emphasis on children, e.g. asthma, allergy,
neuro-immune disorders, cancers, endocrine
disruption) Around 95M spent!
12
Implementing Action 6
asthma and
allergies and childrens health
13
Implementing Action 6
neuroimmune disorders
14
Implementing Action 6
neuroimmune disorders
15
Implementing Action 6
neuroimmune disorders
16
Implementing Action 6 neuroimmune disorders
17
Implementing Action 6
neuroimmune disorders
18
Implementing Action 6 -
cancer
19
Implementing Action 6 -
cancer
20
Implementing Action 6 -
endocrine-mediated effects
21
Implementing Action 6 -
endocrine-mediated effects
22
Implementing Action 6 -
endocrine-mediated effects
23
Implementing Action 6 addressing all 4 priority
diseases
24
Implementing Action 7 Developing methodologies to
assess better the risks coming from environmental
factors and improving economic valuation
(externalities concept) and impact analyses of
prevention strategies Around 30M spent!
25
Implementing Action 7 FP6 projects (2002-2006)
26
Implementing Action 7 FP6 projects (2002-2006)
27
Implementing Action 7 FP6 projects (2002-2006)
28
Implementing Action 7 FP6 projects (2002-2006)
29
Implementing Action 7 FP6 projects (2002-2006)
30

• Action 8
• Launching research on emerging issues
• climate change health (e.g., spreading of
  emerging diseases)
• water pollution (e.g., emerging pathogens in
  drinking water)
• Around 27M spent!

31
Implementing Action 8 - Climate change and health
32
Implementing Action 8 -Water pollution
33
Implementing Action 8
-Water pollution
34
Research projects especially relevant to Action 3
(biomonitoring)
35
DISSEMINATION ACTIVITIES
36
Websites
37
Websites
38
Publications
39
Publications - Planned
40
Dissemination to policy makers and other
stakeholders

• Many projects disseminate directly to
  stakeholders via workshops, newsletters, Open
  Fora e.g., CREDO cluster, CASCADE NoE, EDEN IP,
  ESBIO CA
• DG Research send project Final report summaries
  to regulatory DGs when deemed appropriate
• Project results contribute to Opinions elaborated
  by various Committees (e.g., SCHER of DG SANCO)
• DG Research organises targeted Workshops e.g.,
  in 2005
• Climate change and health
• Endocrine disrupter testing
• Air pollution
• European birth cohorts
• Human biomonitoring

41
Upcoming Events
42
Thank you for your attention
43
Thank you for your attention
44
Relevant to Action 3
45
Relevant to Action 3
46
Relevant to Action 3